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Abstract—Discovering similar diseases can provide valuable
clues for revealing their pathogenesis and predicting therapeutic
drugs. Current methods for the measurement of disease similarity
are mostly based on either semantic associations among diseases
or functional associations between disease and related genes.
In either case, quantitative data are required. However, such
data are not always available. Moreover, many of these methods
only use a single metric to evaluate disease similarity from an
individual data source, which may lead to biased conclusions
lacking consideration of other aspects. In this study, we propose
a novel framework, namely RADAR, for learning representations
for diseases to measure their similarities. RADAR calculates
disease similarity by different measurements fully based on the
associations between diseases and other disease-related data,
and constructs a multi-layer similarity network by integrating
multiple disease similarity networks derived from multiple data
sources in order to provide a comprehensive evaluation of disease
similarities. A benchmark set and 90 random sets were used
to assess the performance of RADAR. Experimental results
demonstrated that RADAR is effective for detecting similar
diseases.
Index Terms—disease similarity, disease information network,
representation learning
I. INTRODUCTION
Identifying similar diseases is meaningful in the domain of
biomedicine. Apart from dedicating to the study of diseases,
disease similarity can be exploited to discover relations among
many other data, such as inferring the relationship among
microRNAs [1], [2], computing the similarity among long non-
coding RNAs [3], [4], [5], [6], [7], and predicting therapeutic
drugs for diseases [8], [9], [10], [11].
In general, there are two typical queries about similar
diseases:
• Top-k query: searching top-k most similar diseases with
respect to a given disease.
• Similar pair query: discovering the most similar disease
pairs from a given disease set.
Similarity of pairwise diseases can be measured by a variety
of aspects including pathogenesis and phenotypes. Existing
methods of measuring disease similarities can be classified
into three categories:
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• Semantics-based: the disease similarity is measured by
the quantitative information of semantic associations a-
mong diseases. The Disease Ontology (DO) [12] is the
first standardized ontology for human diseases based on
the disease terms collected from multiple sources such as
MeSH [13] and OMIM [14]. Thereafter, many methods
have been proposed to calculate disease similarity based
on the terms in DO [15], [16], [17]. Recently, a system
called DOSim [18] was constructed to calculate disease
similarity by implementing 10 representative semantic
similarity measures including the three methods men-
tioned in [15], [16] and [17].
• Function-based: the disease similarity is calculated
by exploiting the relationship among disease-related
genes [19], [20], [21]. For example, the process-similarity
based (PSB) method measures disease similarity by in-
volving the associations between genes based on Gene
Ontology [22] terms.
• Semantics + Function: some researches combine DO-
based similarity with the gene functional associations to
calculate disease similarity. For example, SemFunSim [9]
divides disease similarity into two parts, one obtained
from a weighted gene interaction network from Human-
Net [23], the other obtained from the relationship between
pairwise diseases from DO. The similar idea was adopted
by another method called InfDisSim [24]. Recently, an
online system that implements five advanced methods
was established to calculate similarity between disease
sets [25].
It is worth noting that three disadvantages exist in these
methods mentioned above. First, all of them compute disease
similarity by exploiting some quantitative information about
diseases and other disease-related objects, while the fact is that
the precise numerical data describing the relationship among
objects are not always available. Next, all these methods
compute the disease similarity by a single metric, while it is
very likely that the results will differ under different metrics.
Thus, it is necessary to measure disease similarity under
various metrics. Last but not the least, many of these methods
evaluate disease similarity only from a single data source,
which can lead to biased results that lack of full consideration.
Since two diseases which are regarded as similar based on
one data source do not necessarily share the same similarity
based on another. It would be more comprehensive to evaluate
the disease similarity from a perspective where multiple data
sources can all be considered.
To address these three challenges above, we propose a
novel method, RADAR (short for representation learning across
disease information networks), for similar disease detection.
The characteristics of RADAR include: (1) it flexibly supports
the two typical queries on similar diseases (top-k query and
similar pair query); (2) it computes disease similarity based on
the associations between diseases and other types of disease-
related data; and (3) it evaluates disease similarity based on
multiple data sources under orthogonal (i.e. semantic and
structural) similarity metrics.
The main contributions of this work are as follows:
• We propose RADAR, a general framework for learning
latent representations for diseases that reflect their sim-
ilarities from a perspective where multiple data sources
are considered at the same time, and such representations
can be further applied to detect similar diseases.
• We show how RADAR computes the similarity between
pairwise diseases under various similarity metrics, while
solely based on the relationship between diseases and
other types of related objects without references to any
accurate numerical data.
• We evaluate RADAR on a benchmark set and random
sets to demonstrate its effectiveness in discovering similar
diseases.
The rest of the paper is organized as follows. The related
work is reviewed in Section II, and the design of RADAR is
presented in details in Section III. The experiments based on
real-world data is carried out in Section IV and Section V
concludes the paper.
II. RELATED WORK
Many studies such as [26] [27] [28] have shown that by
analyzing the similarity from a view where multiple data
sources are all under consideration, the better performances
can be achieved in discovering similar objects.
To compute the similarity between pairwise diseases is
actually the process of building a similarity network. Fusing
multiple similarity networks on the basis of samples was
recently proposed in SNF [26]. It first builds several sample-
similarity networks for different data types and then fuses
all these networks into a single similarity network, which
represents the full spectrum of the underlying data. It is dis-
tinctive in iteratively updating each similarity network with the
information from the others, and at last, all similarity networks
are fused into one. During the process of fusing networks, the
weak similarities disappear while the strong similarities are
kept. This may lead to lost of original information.
Another approach integrates various omics data based on a
multiplex network to identify cancer subtypes [27]. Similar to
SNF, it first constructs a patient-wise similarity network for
each given dataset and then it uses a coupling strength to link
each node with its counterparts in different network slices to
build the multiplex networks.
Recently, a new method called FNSemSim [28] was pro-
posed to improve calculating disease similarity. FNSemSim
fuses two gene functional networks into one network and ap-
plies a random walk with restart to compute disease similarity.
FNSemSim refers to the weights of pairwise genes given in the
existing functional gene networks FunCoup and HumanNet
as the connection weights in the fused functional association
network.
The representation learning technique has been widely ap-
plied to a wide range of applications including image analysis,
speech recognition and so on. It is prominent in capturing the
essential semantics of objects by presenting them as dense
vectors in low-dimensional space. Among miscellaneous rep-
resentation learning models, Skip-Gram [29] has been proved
to be very efficient in learning embeddings for textual data
such as words and sentences.
Network representation learning was first proposed by
DeepWalk [30], which considers that nodes with closer lo-
cations in the network are likely to have similar contexts.
Thus, DeepWalk generates sequences for nodes by carrying out
random walks on the network and then uses the Skip-Gram
model to learning embeddings from such sequences. Later,
an improved method called node2vec was proposed to learn
features for nodes that maximize the probability of preserving
the network neighborhoods of nodes [31]. It uses a second
order biased random walk to generate contexts for nodes
to capture the homophily as well as structural equivalence.
This method is more flexible compared with the previous
method for generating contexts. However, all these methods
are designed for the homogenous networks and cannot be
directly applied to heterogenous networks.
III. THE DESIGN OF RADAR
To answer the two typical queries on similar diseases, the
key point of RADAR is constructing the disease similarity
network, which is an undirected graph describing the simi-
larities among diseases. To begin with, a disease information
network will be built from each data source, which is a typical
heterogeneous information network defined as:
Definition 1 (Disease Information Network): A disease
information network (DIN) is a graph G = (V,E) with an
object mapping function ϕ : V → A and a link mapping
function ψ : E → R, where A refers to the set of disease-
related object types and R denotes the set of all relations. Each
object v ∈ V belongs to an object type ϕ(v) ∈ A, and each
link e ∈ E belongs to a relation ψ(e) ∈ R.
Due to the space limitation, please refer to [32] for the de-
tails of the process of building a disease information network
from a given data source, considering this is not the focus in
our study.
Definition 2 (Disease Similarity Network): A disease sim-
ilarity network (DSN) is an undirected graph S = (D, E)
composed of a set of nodes and a set of edges, where each
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Fig. 1. The similar disease detection framework of RADAR
node d ∈ D corresponds to a disease and each edge e ∈ E
refers to the similarity between two diseases that it connects.
In the case of multiple data sources, RADAR connects the
same disease nodes existing in different DSN. That is, a multi-
layer DSN is constructed, based on which the similar query
can be performed.
Figure 1 illustrates the main steps of the RADAR framework.
Step 1 Single-layer DSN Construction: For a disease infor-
mation network, calculate the semantic similarity and
structural similarity between every disease pair by two
similarity measurements and combine them to get one
disease similarity network. (Section III-A)
Step 2 Multi-layer DSN Construction: Associate all the
disease similarity networks obtained in the previous
step into a multi-layer disease similarity network and
conduct the biased random walks on it to generate a
context for every disease. (Section III-B)
Step 3 Similarity query over Embeddings: Apply the Skip-
Gram model to learn the latent representation for each
disease from its context. (Section III-C)
Next, we introduce each step of RADAR in details.
A. Single-layer Disease Similarity Network Construction
In a disease information network, two diseases can be
connected through different paths. The meta path [32] is
defined in as follows:
Definition 3 (Meta Path): A meta path P is a path defined
on the information network and is denoted in the form of
A1
R1−→ A2
R2−→ ... Rl−→ Al+1, where R = R1 ◦R2 ◦ ... ◦Rl is
a composite relation between object type A1 and Al+1, with
◦ denoting the composition operator on relations.
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Specifically, a meta path P is a disease meta path if the
two end nodes of P are two diseases belonging to D.
Definition 4 (Disease Path Instance Set): Given a disease
meta path P in a DIN, the disease path instance set, denoted by
Ins(Pd→d′), is a set of paths which go from d to d′ following
P , where d, d′ ∈ D.
Example 1: Figure 2 shows an example of disease in-
formation network. There are in total four types of objects
{D,G,P,C}. Multiple disease meta paths can be found such
as “D-G-D” (short for “Disease-Gene-Disease”), indicating
two diseases caused by the same gene, with disease path
instances like “d1−g1−d2” and “d3−g2−d4”. And the disease
meta path “D-C-D” (short for “Disease-Chemical-Disease”)
indicates two diseases that can be both treated with the same
chemical, with disease path instances such as “d7 − c2 − d5”
and “d8 − c3 − d5”.
Observation 1: In a disease information network, two dis-
eases are more similar if (1) they share more relationships with
other objects, and (2) they are connected via a short disease
meta path.
Example 2: In the disease information network shown in
Figure 2, d8 is more similar to d5 compared with d7 to d5,
since d8 and d5 have three common paths {d8− c2−d5, d8−
c3 − d5, d8 − g3 − d5} while d7 and d5 only share one path
{d7 − c2 − d5}. Besides, d8 and d1 are unlikely to be similar
compared with d2 to d1. This is because the disease meta
path connecting d1 and d8 is too long, which indicates a loose
relationship between them.
RADAR starts with the construction of a disease similarity
network from a single disease information network under two
orthogonal similarity measurements, i.e., semantic similarity
and the structural similarity.
1) Measuring Semantic Similarity: In a heterogenous net-
work, the meta path, which captures subtle semantics of the
nodes that pass through [32], is usually used to imply the
relationship between two nodes. A meta path-based similarity
measure called PathSim [32] was proposed to find similar
peer nodes in a network and has received fairly good effects.
Analogously, RADAR searches similar diseases in a disease
information network by a certain disease meta path that
indicates the semantic relationship between two diseases.
The semantic similarity between disease d1 ∈ D and disease
d2 ∈ D is defined as:
SemSim(d1, d2) =
2× |Ins(Pd1→d2)|
|Ins(Pd1→d1)|+ |Ins(Pd2→d2)|
(1)
where |Ins(Pd1→d2)| is the number of path instances from
d1 to d2 under the given disease meta path, |Ins(Pd1→d1)| is
that from d1 to d1, and |Ins(Pd2→d2)| is that from d2 to d2.
Clearly, 0.0 ≤ SemSim(d1, d2) ≤ 1.0.
By traversing the whole network, RADAR computes the
semantic similarity for every disease pair based on the defined
disease meta path according to Equation 1.
2) Measuring Structural Similarity: It may be noted that
the disease path-based similarity measurement introduced
above can only capture the relationship between two nodes on
each end of the path and may fail to discover more potential
similar nodes due to the constraint of the disease path.
Example 3: In Figure 2, d2 and d3 will not be considered to
be similar under the disease path “D-G-D”, even if they both
share one related chemical and one protein.
An approach was given in [33] to calculate the similarity
among nodes solely based on their structural identities in a
network, which succeeds in discovering more similar node
pairs. Thus, RADAR further assess the similarity between
two diseases based on the structural identities of the disease
network.
In a disease information network, the structure of a node d
can be described by that of its vicinity, which is composed of
a set of nodes belonging to the same object type as d. We call
this set of nodes as the ϵ-Neighbor Set defined as:
Definition 5 (ϵ-Neighbor Set): In a disease information
network, we denote ℓϵ(d) the set of nodes which are ϵ hop(s)
(ϵ ≥ 1) from d, where d ∈ D.
Example 4: In Figure 2, for d2, ℓ1(d2) = {d1, d3, d6, d7}
and ℓ2(d2) = {d4, d5, d8}. That is, d2 has four 1-hop neigh-
bors and three 2-hop neighbors.
Observation 2: In a disease information network, nearer
neighbors make more contribution to describe the structural
identity of a node.
Inspired by the idea of Katz centrality [34], a decaying
weight factor is introduced to penalize the distant neighbors
of a node.
In a disease information network, the number of edges
incident to a disease node d ∈ D is the degree of d. We
denote DS(ℓϵ(d)) the degree sequence of each disease node in
ℓϵ(d) sorted in ascending order. Let α be the decaying weight
factor that determines the importance of vicinities of disease
nodes at different hops. Given a disease information network
containing a set of diseases D, the structural distance between
two disease nodes d1, d2 ∈ D is defined as:
StrDisϵ(d1, d2) = StrDisϵ−1(d1, d2) +
αϵ × T (DS(ℓϵ(d1)), DS(ℓϵ(d2))) (2)
where StrDis0(d1, d2) = 0, and T (DS(ℓϵ(d1)), DS(ℓϵ(d2)))
measures the distance between two ordered degree sequences
DS(ℓϵ(d1)) and DS(ℓϵ(d2)). In RADAR, the Dynamic Time
Warping (DTW) [35] method is adopted to calculate the
distance between two sequences, as DTW has been proved
to be very effective in handling numerical sequences by
using some optimal alignment strategies to ensure the distance
of two sequences is minimal. Specifically, for two ordered
degree sequences DS1 and DS2, the distance between the i-
th element in DS1 (denoted by DS1[i]) and the j-th element
in DS2 (denoted by DS2[j]) is defined as:
dis(DS1[i], DS2[j]) =
max(DS1[i], DS2[j]) + λ
min(DS1[i], DS2[j]) + λ
− 1 (3)
where λ is a parameter preventing dis(·) being too large. (We
set λ = 0.5 as in [33].)
For any disease node d ∈ D, as the hop count ϵ increasing,
the according ring of its neighborhood takes less importance
with regards to d, since α gives more penalty to the further
neighborhood. In such sense, it would be meaningless to go
too far from d. Therefore, RADAR only takes the first several
rings of neighbors of d into consideration when describing the
structural identity of d. The decaying weight factor α as well
as the hop count ϵ will be evaluated in the experiment to test
their impacts on RADAR.
The natural exponential function is used to restrict the value
of similarity in the range between 0.0 and 1.0 and the final
structural similarity between d1 and d2 is
StrucSim(d1, d2) = e
−StrDisϵ(d1,d2) (4)
For any disease pair, RADAR first gets their degree se-
quences at each ring of neighborhoods starting from them-
selves to their ϵ-hop neighborhoods. Then RADAR computes
their structural similarity according to Equation 4.
3) Similarity Combination: After measuring the disease
similarity under two orthogonal measurements on a disease
information network, two sets of disease similarities have been
obtained. Now RADAR merges these similarities together to
build a united DSN. While the arithmetic mean of the two
similarities is used to get the final disease similarity (ranging
between 0.0 and 1.0), any other merging methods can be
adopted by RADAR to combine the similarities obtained under
any other metrics besides SemSim and StrucSim.
B. Multi-layer Disease Similarity Network Construction
Though calculated by the same measurements, the DSNs
obtained from multiple disease information networks are dif-
ferent from each other due to the characteristics of the disease
information networks differ. To best keep the original infor-
mation about every DSN, RADAR integrates all the DSNs into
a multi-layer DSN. Specifically, each disease node locating in
one DSN is associated with its counterpart in another by an
edge with the weight set to 1.
Compared with SNF [26], the main advantage of RADAR
is that the multi-layer DSN is constructed without lost of any
information about the original DSN, while SNF fuses multiple
similarity networks into a single one, only keeping the strong
similarities but losing the weak ones.
Next, RADAR generates a context for each disease node
by conducting random walks, particularly the biased random
walks over the multi-layer DSN. Before each step, a random
number will be generated, based on which the walker then
decides whether to walk in the current network or to change to
another one. If the walker stays in the current layer, it prefers
walking towards a node that is more similar to the current
node, i.e., it will walk along an edge among those with a
bigger weight. If the walker changes the layer, no step will
be made in this turn. In this way, the sequence of a node
generated by the walker will be composed of a series of its
similar nodes.
In summary, RADAR first starts from a random layer at
a random disease node. Then the biased random walks are
conducted for every disease node and its context will be
produced accordingly in the end. By walking in the multi-layer
DSN, the context generated is able to capture the similarity
relationships for a disease node from multiple perspectives.
C. Similarity Query over Embeddings
The Skip-Gram model is adopted by RADAR to learn em-
beddings for all disease nodes based on the contexts generated
by the biased random walks on the multi-layer DSN. In such
way, the embeddings of nodes have successfully captured the
similarities derived from multiple disease information net-
works. Note that besides Skip-Gram, any other representation
learning models can be used in RADAR to learn embeddings
for diseases.
Finally, the disease similarity can be calculated by applying
a favorable distance measurement, such as the cosine, to their
embeddings. The framework of RADAR is summarized in
Algorithm 1.
Algorithm 1 RADAR (N )
Input: N : the set of disease information networks
Output: R: the results of similar disease query
1: G ← ∅
2: for N ∈ N do
3: compute semantic similarity and structural similarity for
every pair of diseases in N
4: G← the single-layer DSN constructed from N
5: G ← G ∪ {G}
6: end for
7: Connect the same disease nodes in different layers in G
8: Generate contexts Con by conducting the biased random
walks on G
9: Learn embeddings M for all nodes from Con
10: R ← Perform similar disease query over M
11: return R
TABLE I
CHARACTERISTICS OF THE DISEASE INFORMATION NETWORKS
DIN Type of Nodes # of Nodes # of Edges
Dis-Gene disease 2818 117191genes 9658
Dis-PTC disease 916 11134chemicals 3516
IV. EXPERIMENTS AND RESULTS DISCUSSION
In this section, we evaluate the ability and performance
of RADAR in answering the similarity queries with capturing
the semantics and structural identities of diseases in multiple
disease information networks.
A. Datasets
We applied RADAR to the datasets provided by [9] to search
similar diseases. One dataset contains associations between
diseases and genes, based on which a disease information
network called “Dis-Gene” was built. The other one contains
associations between diseases and potential therapeutic chem-
icals (PTC), based on which a disease information network
called “Dis-PTC” was built. Table I lists the characteristics of
these two disease information networks.
B. Effectiveness
We adopted the benchmark set given by [9] as the positive
samples, which contains disease pairs that have been con-
firmed to be similar. Besides, 90 random sets were generated
and adopted as the negative samples, which were regarded as
dissimilar disease pairs. We applied RADAR on this benchmark
set as well as the random sets to test its effectiveness of finding
similar diseases. Throughout this experiment, the running
parameters were set as α = 0.5 and ϵ = 2 in default.
To the best of our knowledge, RADAR is the first work
that measures disease similarity from multiple data sources
under the combination of semantic and structural similarity
measurements. We verified the necessities of (1) measuring
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Fig. 3. The performance analysis of combining similarities under the semantic
similarity measurement and the structural similarity measurement.
disease similarity under two orthogonal metrics, (2) mea-
suring disease similarity across different disease information
networks, respectively.
First, we compared RADAR with its two variations. Specif-
ically, we implemented two versions of RADAR. One only
computed the semantic similarity (Equation 1), which was
called “RADRA-Sem”. The other one only computed the
structural similarity (Equation 4), which was called “RADRA-
Stru”.
Figure 3 illustrates the Receiver Operating Characteris-
tic (ROC) curves drawn for RADAR, “RADRA-Sem” and
“RADRA-Stru”, respectively. Clearly, RADAR achieved the
best performance with an Area under the ROC Curve (AUC) of
0.8465, while “RADRA-Sem” and “RADRA-Stru” performed
relatively poorly with the AUCs of 0.8005 and 0.7206, re-
spectively. Nevertheless, all of them did much better than the
random performance. This demonstrated that combining the
similarities computed under two types of similarity metrics
is more effective than only using one of them for detecting
similar diseases.
Second, we applied RADAR on the “Dis-Gene” DIN, the
“Dis-PTC” DIN, and both of the DINs, respectively, to eval-
uate the necessity of integrating different similarity networks
obtained from different datasets.
Figure 4 shows the ROC curves drawn for “Dis-Gene +
Dis-PTC”, “Dis-Gene” and “Dis-PTC”, respectively. Clearly,
“Dis-Gene + Dis-PTC” achieved the best result, followed
by “Dis-Gene” and “Dis-PTC” with the AUC of 0.7898
and 0.7380. This indicates that integrating multiple similarity
networks is more effective than only using a single similarity
network for detecting similar diseases.
From the results above, we can see that by adopting the
combination of various similarity measurements and integrat-
ing multiple similarity networks together, a better performance
can be achieved for the detection of similar diseases.
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Fig. 4. The performance analysis of integrating multiple similarity networks.
Next, we evaluated the performances of RADAR in search-
ing top-k most similar diseases for a given query and discov-
ering the most similar disease pairs in a given disease set,
respectively.
Several diseases were randomly selected from the bench-
mark set as the queries, and a result list comprising the top-5
most similar diseases to each of the queries was generated
by RADAR. The results were recorded in Table II. Take
Alzheimer’s Disease for example, RADAR discovered that
hypertension was most similar to it in the given disease set.
A good amount of studies can be found to prove their close
relationship. Next, we searched in the whole disease set to
find the most similar disease pairs. The top 10 most similar
disease pairs found by RADAR in the given disease set were
recorded in Table III. These two sets of results above verified
that RADAR performed well in fulfilling the tasks of top-k
query and similar pair query.
C. Running Parameter Analysis
1) α: We first evaluated the impact of assigning the de-
caying weight factor with different values when computing
the structural similarity as introduced in Section III-A2. The
ROC curves were presented in Figure 5. As expected, despite
RADAR did the best when α = 0.3, there were just very trivial
differences among all results, which implies that RADAR is
insensitive to α.
2) ϵ: We evaluated the hop count ϵ when measuring the
structural similarity as described in Section III-A2. The ROC
curves were shown in Figure 6. As presented, RADAR had
the best performance when ϵ = 5. This is probably because
that a bigger vicinity is considered when ϵ is under this
value compared with the others, and a bigger vicinity of a
node covers a wider area of its neighbors, which can provide
more information about the structural identities for the node.
However, the difference among these results was very trivial,
TABLE II
TOP-k SIMILAR DISEASES FOR THE GIVEN QUERIES
Query Top-5 results Score
Alzheimer’s Disease
hypertension 0.7223
obesity 0.7119
melanoma 0.6996
cerebrovascular accident 0.6989
ovarian cancer 0.6927
Diabetes Mellitus
pre-eclampsia 0.7579
coronary heart disease 0.7462
brain ischemia 0.7414
leukemia 0.7285
cerebrovascular accident 0.7162
Myocardial Infarction
congestive heart failure 0.7080
melanoma 0.6833
atherosclerosis 0.6744
kidney disease 0.6631
brain ischemia 0.6602
Rheumatoid Arthritis
coronary arteriosclerosis 0.6357
juvenile rheumatoid arthritis 0.6312
squamous cell carcinoma 0.6257
atherosclerosis 0.6186
diabetes mellitus 0.6168
Epilepsy
vascular disease 0.6504
hypersensitivity reaction disease 0.6466
liver disease 0.6390
hypertrophic cardiomyopathy 0.6311
glucose intolerance 0.6157
TABLE III
THE MOST SIMILAR DISEASE PAIRS
Similar Disease Pair Score
(melanoma, atherosclerosis) 0.8029
(neurodermatitis, functional colonic disease) 0.7908
(acrodermatitis enteropathica, acrodermatitis) 0.7861
(retrograde amnesia, alcoholic psychosis) 0.7829
(urinary bladder cancer, squamous cell carcinoma) 0.7805
(neurodermatitis, alcoholic psychosis) 0.7777
(brain ischemia, coronary heart disease) 0.7645
(leukemia, squamous cell carcinoma) 0.7644
(ovarian cancer, squamous cell carcinoma) 0.7628
(cerebrovascular accident, squamous cell carcinoma) 0.7626
which means the value of ϵ has not exerted so big influence
on measuring structural similarity.
V. CONCLUSION
Similar disease detection is an important issue in the field
of biomedicine. Most of the existing methods search similar
diseases based on numerical data, but this requirement can
not always be met. Besides, many of them evaluate disease
similarity only under a single metric and only from a single
data source.
We propose RADAR, a general framework for learning
representations for diseases that capture their semantics and
structural identities from a more comprehensive perspective.
Such representations can be used to detect similar diseases.
RADAR is unique in computing disease similarity under vari-
ous metrics, solely based on the associations between diseases
and other types of biomedical objects without referring to any
numerical information.
The performance of RADAR was evaluated based on a
benchmark set as well as 90 random sets. The high AUC
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(0.8465) indicates RADAR is effective in discovering similar
diseases. Besides, RADAR provides a novel way to discover
the relationship between disease pairs by maximizing the
exploitation of associations among multiple disease-related
data. This may facilitate relevant studies and can be further
improved to achieve more accurate results.
For the future work, we will focus on the following tasks to
improve RADAR. The scalability of RADAR can be improved
so that it can be applied to large-scale datasets smoothly.
When combining similarities obtained under various similarity
metrics, an improved merging method can be designed to
better balance the importance of those metrics. When building
the multi-layer similarity network, advanced techniques such
as object recognition and object matching may be adopted
to allow diseases from various data sources with different
representations to match with each other. Improvement may
also be made to allow real-time update of the multi-layer
network when a new data source is added.
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